Jazz Pharmaceuticals target price raised to $305 from $296 by RBC
JAZZ•RBC raised its target price for Jazz Pharmaceuticals to $305 from $296.
Related News
Carl Icahn’s CVR Energy reportedly near deal for Marathon refineries valued at over $4 billion
MPC•
Morgan Stanley is a dubious saviour for UBS
UBS•
KBW cuts Walker & Dunlop target price to $43 from $45
WD•
Nvidia reportedly orders data centre clients to reduce China exposure
NVDA•
Nasdaq price objective raised to $135 from $133
NDAQ•